Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/50BA stock hub

FRA/50BA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/50BAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

284.9M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/50BAFRA/50BA

—

Loading chart…

In the news

Latest news · FRA/50BA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-21.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/50BA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

124

Groups with data

Currency

USD

Showing 124 of 124 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	288
Employees Change	21%
Employees Change Percent	7.39
Enterprise value	EUR -234.5M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 284.9M
Price	EUR 4.06
Price currency	EUR
Rev Per Employee	191,215.56x
Sic	2836
Symbol	fra/50BA
Website	https://www.bicycletherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-66.68%
EV Earnings	1.23x
P/B ratio	0.54x
P/S ratio	5.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-260.78%
Gross Profit	EUR -143.6M
Net Income	EUR -190M
Pretax Margin	-342.71%
Profit Per Employee	EUR -659,573
Roa5y	-17.54
Roe5y	-36.67
ROIC	-21.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-38.04%
Cagr3y	-39.34%
Cagr5y	-30.59%
Revenue Growth	146.86x
Revenue Growth Q	-91.11x
Revenue Growth3 Y	60.01x
Revenue Growth5 Y	41.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	EUR 544.8M
Debt	EUR 14.6M
Debt Equity	EUR 0.03
Equity	EUR 529M
Interest Coverage	-1,173.1
Net Cash	EUR 530.1M
Net Cash By Market Cap	EUR 186
Net Cash Growth	-22.1%
Net Debt Equity	EUR -1
Tangible Book Value	EUR 529M
Tangible Book Value Per Share	EUR 7.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-38.02%
200-day SMA	5.48
3Y total return	-77.69%
50-day SMA	4.17
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.89%
All Time High	52
All Time High Change	-92.19%
All Time High Date	2021-11-04
All Time Low	3.6
All Time Low Change	12.78%
All Time Low Date	2026-03-30
ATR	0.17
Ch YTD	-26.18
High	4.06
High52	8.1
High52 Date	2025-05-13
High52ch	-49.88%
Low	3.98
Low52	3.6
Low52 Date	2026-03-30
Low52ch	12.78%
Ma50ch	-2.54%
Price vs 200-day SMA	-25.84%
RSI	48.09
RSI Monthly	33.78
RSI Weekly	38.15
Sharpe ratio	-0.66x
Sortino ratio	-0.82
Total Return	-6.99%
Tr YTD	-26.18
Tr3m	-12.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -206.5M
Operating margin	-375.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Insiders	1.8%
Shares Institutions	35.25%
Shares Qo Q	0.46%
Shares Yo Y	6.99%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	12.5x
Bv Per Share	7.63
Ch1y	-38.02
Ch3m	-12.12
Ch3y	-77.69
Ch5y	-83.89
Ch6m	-26.18
Change	-4.69%
Change From Open	1.5
Close	4.26
Days Gap	-6.1
Depreciation Amortization	5,421,445
Earnings Date	2026-08-03
EBIT	EUR -206.5M
EBITDA	EUR -201M
EPS	EUR -2.74
F Score	1
Fiscal Year End	December
Founded	2,009
Income Tax	EUR 1.2M
Is Primary Listing	0
Last Earnings Date	2026-02-20
Last Report Date	2026-03-31
Ma150	5.22
Ma150ch	-22.15%
Ma20	4.15
Ma20ch	-2.07%
Next Earnings Date	2026-08-03
Open	4
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	0.54
Relative Volume	13.74x
Revenue	55,070,081x
Tax By Revenue	2.22x
Tr6m	-26.18%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/50BA pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/50BA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/50BA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.3%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.0%

Negative means the company is buying back shares.

Technical

FRA/50BA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.1

Neutral momentum band

Price vs 200-day MA

-25.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/50BA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/50BA stock rating?

fra/50BA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/50BA analysis?

The full report lives at /stocks/fra/50BA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/50BA?

The latest report frames fra/50BA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/50BA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.